Cargando…
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
The dysregulation of gene expression is a critical event involved in all steps of tumorigenesis. Aberrant histone and non-histone acetylation modifications of gene expression due to the abnormal activation of histone deacetylases (HDAC) have been reported in hematologic and solid types of cancer. In...
Autores principales: | Ruzic, Dusan, Djoković, Nemanja, Srdić-Rajić, Tatjana, Echeverria, Cesar, Nikolic, Katarina, Santibanez, Juan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778744/ https://www.ncbi.nlm.nih.gov/pubmed/35057104 http://dx.doi.org/10.3390/pharmaceutics14010209 |
Ejemplares similares
-
Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma
por: Djokovic, Nemanja, et al.
Publicado: (2023) -
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
por: Beljkas, Milan, et al.
Publicado: (2023) -
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation
por: Ruzic, Dusan, et al.
Publicado: (2022) -
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
por: Gagic, Zarko, et al.
Publicado: (2020) -
Current and Future Cancer Chemoprevention Strategies
por: Santibanez, Juan F., et al.
Publicado: (2023)